These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35581243)

  • 21. Thoracic duct and cisterna chyli: evaluation with multidetector row CT.
    Kiyonaga M; Mori H; Matsumoto S; Yamada Y; Sai M; Okada F
    Br J Radiol; 2012 Aug; 85(1016):1052-8. PubMed ID: 22253338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites.
    Arase Y; Kagawa T; Tsuruya K; Sato H; Teramura E; Anzai K; Hirose S; Deguchi R; Shiraishi K; Mine T
    Clin Drug Investig; 2019 Jan; 39(1):45-54. PubMed ID: 30284699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis.
    Sakaida I; Terai S; Nakajima K; Shibasaki Y; Tachikawa S; Tsubouchi H
    J Gastroenterol; 2017 Feb; 52(2):229-236. PubMed ID: 27379386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema.
    Sakaida I; Yamashita S; Kobayashi T; Komatsu M; Sakai T; Komorizono Y; Okada M; Okita K;
    J Int Med Res; 2013 Jun; 41(3):835-47. PubMed ID: 23685892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging.
    Verma SK; Mitchell DG; Bergin D; Lakhman Y; Austin A; Verma M; Assis D; Herrine SK; Parker L
    Abdom Imaging; 2009; 34(2):211-6. PubMed ID: 18219518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphology of the cisterna chyli in nine dogs with idiopathic chylothorax and in six healthy dogs assessed by computed tomographic lymphangiography.
    Rengert R; Wilkinson T; Singh A; Brisson BA; Fransson B
    Vet Surg; 2021 Jan; 50(1):223-229. PubMed ID: 33175400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis.
    Uojima H; Hidaka H; Tanaka Y; Wada N; Kubota K; Nakazawa T; Shibuya A; Sung JH; Kako M; Koizumi W
    Dig Dis; 2020; 38(1):38-45. PubMed ID: 31216537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cisterna chyli diameter with MRI in patients with chronic kidney disease.
    Albayrak E; Ozmen Z; Sahin S; Demir O; Erken E
    J Magn Reson Imaging; 2016 Oct; 44(4):890-6. PubMed ID: 27016110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites.
    Sagawa E; Okubo H; Ando H; Sorin Y; Kanazawa R; Nakadera E; Fukada H; Kokubu S; Miyazaki A
    J Pharmacol Sci; 2019 Apr; 139(4):373-376. PubMed ID: 30857764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cisterna chyli: a systematic review of definition, prevalence, and anatomy.
    Moazzam S; O'Hagan LA; Clarke AR; Itkin M; Phillips ARJ; Windsor JA; Mirjalili SA
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H1010-H1018. PubMed ID: 36206050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites.
    Hiramine Y; Uto H; Mawatari S; Kanmura S; Imamura Y; Hiwaki T; Saishoji A; Oku M; Tokushige K; Maenohara S; Ido A
    J Gastroenterol; 2021 Jan; 56(1):54-66. PubMed ID: 32959093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging appearance of the Cisterna chyli.
    Johnson VS; Seiler G
    Vet Radiol Ultrasound; 2006; 47(5):461-4. PubMed ID: 17009507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisterna chyli: An important landmark in laparoscopic paraaortic lymphadenectomy.
    Dogan NU; Dogan S; Erol M; Uzun BT
    Gynecol Oncol; 2020 Feb; 156(2):511. PubMed ID: 31892416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis.
    Okita K; Sakaida I; Okada M; Kaneko A; Chayama K; Kato M; Sata M; Yoshihara H; Ono N; Murawaki Y
    J Gastroenterol; 2010 Sep; 45(9):979-87. PubMed ID: 20387081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of thoracic duct dilatation in patients with chronic liver disease.
    Park SW; Kim TH; Ham SY; Um SH; Goh HG; Lee S; Lee HA; Yim SY; Seo YS; Yim HJ; An H; Oh YW
    Medicine (Baltimore); 2020 May; 99(22):e19889. PubMed ID: 32481363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrograde cannulation of the thoracic duct and embolization of the cisterna chyli in the treatment of chylous ascites.
    Mittleider D; Dykes TA; Cicuto KP; Amberson SM; Leusner CR
    J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):285-90. PubMed ID: 18341963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial.
    Wang YF; Tang JT; Han T; Ding HG; Ye WJ; Wang MR; Cheng J; Yang YP; Chen CW; Xie Q; Mao Q; Niu JQ; Wang ZH; Wei Z; Chen YX; Zeng M; Mao YM
    J Dig Dis; 2018 Mar; 19(3):144-154. PubMed ID: 29389068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial.
    Tang J; Wang Y; Han T; Mao Q; Cheng J; Ding H; Shang J; Zhang Q; Niu J; Ji F; Chen C; Jia J; Jiang X; Lv N; Gao Y; Wang Z; Wei Z; Chen Y; Zeng M; Mao Y
    BMC Gastroenterol; 2020 Nov; 20(1):391. PubMed ID: 33213378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cisterna chyli ablation in three cats with idiopathic chylothorax].
    Thiel C; Held S; Kramer M
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2013; 41(4):221-8. PubMed ID: 23958705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.